LAMISIL AT
Live / Registered — Registered and renewed (as of 19 Aug 2020)
What this means for you
Registered since 03 Jul 2001. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 03 Jul 2021).
Record
- Serial number
- 75638238
- Registration number
- 2466269
- Mark type
- Word mark
- Filed
- 16 Feb 1999
- Published for opposition
- 09 Nov 1999
- Registered
- 03 Jul 2001
- Next maintenance due
- 03 Jul 2021
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations, namely, an antifungal
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 19 Aug 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 19 Aug 2020 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 19 Aug 2020 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 19 Aug 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jul 2020 — TEAS SECTION 8 & 9 RECEIVED
- 03 Jul 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 10 Nov 2015 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Nov 2015 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Jul 2010 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 21 Jul 2010 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Jul 2010 — TEAS SECTION 8 & 9 RECEIVED
- 22 Jan 2008 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Dec 2006 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Oct 2006 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 03 Oct 2006 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED